Haplox Biotechnology Co., Ltd, a Chinese biotech firm, and US industry leader Illumina (NASDAQ: ILMN) have jointly announced the production line completion of the first NextSeq 2000Dx-CN-HAP gene sequencing system, a domestically produced product manufactured in Shenzhen. The collaboration will now concentrate on local manufacturing of high-end life sciences equipment in the Greater Bay Area.
The NextSeq 2000 series gene sequencing system features over 75 technological innovations and integrates the bioinformatics analysis capabilities of onboard DRAGEN servers. It is capable of completing library amplification, sequencing, and rapid genome analysis in a single, streamlined process. With flexible throughput and read length options, easy operation, and a compact desktop design suitable for various laboratory scales and scenarios, the system offers customers an accurate, adaptable, swift, and straightforward sequencing experience.- Flcube.com
